Nuclear PDCD4 Expression Defines a Subset of Luminal B-Like Breast Cancers with Good Prognosis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nuclear PDCD4 Expression Defines a Subset of Luminal B-Like Breast Cancers with Good Prognosis
Authors
Keywords
-
Journal
Hormones & Cancer
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-07-06
DOI
10.1007/s12672-020-00392-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment
- (2019) Ana C. Garrido-Castro et al. Cancer Discovery
- Next-generation characterization of the Cancer Cell Line Encyclopedia
- (2019) Mahmoud Ghandi et al. NATURE
- Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019
- (2019) H J Burstein et al. ANNALS OF ONCOLOGY
- Revisiting progesterone receptor (PR) actions in breast cancer: Insights into PR repressive functions
- (2018) Cecilia J. Proietti et al. STEROIDS
- A patient-derived explant (PDE) model of hormone-dependent cancer
- (2018) Margaret M. Centenera et al. Molecular Oncology
- Methods to Evaluate Cell Growth, Viability, and Response to Treatment in a Tissue Engineered Breast Cancer Model
- (2017) Kayla F. Goliwas et al. Scientific Reports
- Treating cancer with selective CDK4/6 inhibitors
- (2016) Ben O'Leary et al. Nature Reviews Clinical Oncology
- Cistrome Data Browser: a data portal for ChIP-Seq and chromatin accessibility data in human and mouse
- (2016) Shenglin Mei et al. NUCLEIC ACIDS RESEARCH
- Down-regulation of programmed cell death 4 (PDCD4) is associated with aromatase inhibitor resistance and a poor prognosis in estrogen receptor-positive breast cancer
- (2015) Zhike Chen et al. BREAST CANCER RESEARCH AND TREATMENT
- Progesterone receptor modulates ERα action in breast cancer
- (2015) Hisham Mohammed et al. NATURE
- Stat3 regulates ErbB-2 expression and co-opts ErbB-2 nuclear function to induce miR-21 expression, PDCD4 downregulation and breast cancer metastasis
- (2015) L Venturutti et al. ONCOGENE
- Tumor suppressor PDCD4 inhibits NF-κB-dependent transcription in human glioblastoma cells by direct interaction with p65
- (2014) Soon-Kyung Hwang et al. CARCINOGENESIS
- A novel mechanism for the control of translation of specific mRNAs by tumor suppressor protein Pdcd4: inhibition of translation elongation
- (2014) A Biyanee et al. ONCOGENE
- Targeting ErbB-2 nuclear localization and function inhibits breast cancer growth and overcomes trastuzumab resistance
- (2014) R I Cordo Russo et al. ONCOGENE
- Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
- (2013) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Progesterone receptor expression is an independent prognostic variable in early breast cancer: a population-based study
- (2013) C A Purdie et al. BRITISH JOURNAL OF CANCER
- Tumor suppressor PDCD4 modulates miR-184-mediated direct suppression of C-MYC and BCL2 blocking cell growth and survival in nasopharyngeal carcinoma
- (2013) Yan Zhen et al. Cell Death & Disease
- Clinical relevance of ErbB-2/HER2 nuclear expression in breast cancer
- (2012) Roxana Schillaci et al. BMC CANCER
- Survival and clinicopathological characteristics of breast cancer patient according to different tumour subtypes as determined by hormone receptor and Her2 immunohistochemistry. A single institution survey spanning 1998 to 2010
- (2012) A. García Fernández et al. BREAST
- Prognostic Significance of Progesterone Receptor–Positive Tumor Cells Within Immunohistochemically Defined Luminal A Breast Cancer
- (2012) Aleix Prat et al. JOURNAL OF CLINICAL ONCOLOGY
- The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
- (2012) Christina Curtis et al. NATURE
- Non-Overlapping Progesterone Receptor Cistromes Contribute to Cell-Specific Transcriptional Outcomes
- (2012) Christine L. Clarke et al. PLoS One
- Differential expression of microRNA expression in tamoxifen-sensitive MCF-7 versus tamoxifen-resistant LY2 human breast cancer cells
- (2011) Tissa T. Manavalan et al. CANCER LETTERS
- Down-regulation of PDCD4 expression is an independent predictor of poor prognosis in human renal cell carcinoma patients
- (2011) Xiancheng Li et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Association of microRNA-21 expression with its targets, PDCD4 and TIMP3, in pancreatic ductal adenocarcinoma
- (2011) Yuichi Nagao et al. MODERN PATHOLOGY
- Practical implications of gene-expression-based assays for breast oncologists
- (2011) Aleix Prat et al. Nature Reviews Clinical Oncology
- Mechanisms of Endocrine Resistance in Breast Cancer
- (2010) C. Kent Osborne et al. Annual Review of Medicine
- Defining breast cancer prognosis based on molecular phenotypes: results from a large cohort study
- (2010) Shaheenah Dawood et al. BREAST CANCER RESEARCH AND TREATMENT
- Metastatic Behavior of Breast Cancer Subtypes
- (2010) Hagen Kennecke et al. JOURNAL OF CLINICAL ONCOLOGY
- Progesterone Receptor Induces ErbB-2 Nuclear Translocation To Promote Breast Cancer Growth via a Novel Transcriptional Effect: ErbB-2 Function as a Coactivator of Stat3
- (2010) W. Beguelin et al. MOLECULAR AND CELLULAR BIOLOGY
- Pdcd4 repression of lysyl oxidase inhibits hypoxia-induced breast cancer cell invasion
- (2010) A N Santhanam et al. ONCOGENE
- Programmed cell death 4 protein in esophageal cancer
- (2010) Rugge ONCOLOGY REPORTS
- Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies
- (2010) Fiona M. Blows et al. PLOS MEDICINE
- A fuzzy gene expression-based computational approach improves breast cancer prognostication
- (2010) Benjamin Haibe-Kains et al. GENOME BIOLOGY
- The tumour suppressor Pdcd4: recent advances in the elucidation of function and regulation
- (2009) Brigitte Lankat-Buttgereit et al. BIOLOGY OF THE CELL
- Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma
- (2009) Liqiang Qi et al. BMC CANCER
- An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
- (2009) Balazs Györffy et al. BREAST CANCER RESEARCH AND TREATMENT
- Programmed Cell Death Protein 4 Down-regulates Y-Box Binding Protein-1 Expression via a Direct Interaction with Twist1 to Suppress Cancer Cell Growth
- (2009) M. Shiota et al. CANCER RESEARCH
- Up-regulation of miR-21 by HER2/neuSignaling Promotes Cell Invasion
- (2009) Tzu-Hsuan Huang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
- (2009) Maggie C. U. Cheang et al. JNCI-Journal of the National Cancer Institute
- Loss of Programmed cell death 4 (Pdcd4) associates with the progression of ovarian cancer
- (2009) Na Wei et al. Molecular Cancer
- Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells
- (2009) Nalinie S. Wickramasinghe et al. NUCLEIC ACIDS RESEARCH
- The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti-HER-2 Therapy and Personalized Medicine
- (2009) J. S. Ross et al. ONCOLOGIST
- Activation of Stat3 by Heregulin/ErbB-2 through the Co-Option of Progesterone Receptor Signaling Drives Breast Cancer Growth
- (2008) C. J. Proietti et al. MOLECULAR AND CELLULAR BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now